share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Dmytruk Mark E.

SEC announcement ·  Jan 5 00:00
Summary by Moomoo AI
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], engaged in a series of stock transactions beginning on January 2, 2024. Dmytruk acquired a total of 85,048 shares of Ginkgo Bioworks' Class A Common Stock through the exercise of derivative securities. The following day, on January 3, 2024, he sold 45,794 shares in an open market transaction at a price of $1.54 per share, resulting in a total sale value of $70,522.76. After these transactions, Dmytruk's direct holdings in the company amounted to 716,098 shares. The transactions have been reported as completed.
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], engaged in a series of stock transactions beginning on January 2, 2024. Dmytruk acquired a total of 85,048 shares of Ginkgo Bioworks' Class A Common Stock through the exercise of derivative securities. The following day, on January 3, 2024, he sold 45,794 shares in an open market transaction at a price of $1.54 per share, resulting in a total sale value of $70,522.76. After these transactions, Dmytruk's direct holdings in the company amounted to 716,098 shares. The transactions have been reported as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more